Marc Rubin is a director of Curis Inc.
Person profile
Roles
Address
San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
GALECTIN THERAPEUTICS INC
7 Feb 24
4
GALECTIN THERAPEUTICS INC
30 Jan 23
4
CURIS INC
24 Jan 23
3/A
Medicine Man Technologies, Inc.
2 Dec 22
3
Medicine Man Technologies, Inc.
7 Nov 22
4
CURIS INC
31 Jan 22
4
GALECTIN THERAPEUTICS INC
25 Jan 22
4
TITAN PHARMACEUTICALS INC
5 Jan 22
4
GALECTIN THERAPEUTICS INC
29 Mar 21
4
TITAN PHARMACEUTICALS INC
11 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Jan 24 | GALT Galectin Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.72 | 50,000 | 86.00 k | 50,000 |
26 Jan 23 | GALT Galectin Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.11 | 40,000 | 44.40 k | 40,000 |
23 Jan 23 | CRIS Curis | Non Qualified Stock Option Common Stock | Grant | Acquire A | No | No | 0.75 | 85,000 | 63.75 k | 85,000 |